A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Recruiting · NCT06433752 · Observational (researchers observe without assigning treatment) · Lead sponsor: TG Therapeutics, Inc.

View the official record on ClinicalTrials.gov →

Multiple Sclerosis

Interventions studied

No Intervention

What this trial is about

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Who can take part

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not specified

Study type

Observational (researchers observe without assigning treatment)

Inclusion criteria

Confirmed Multiple Sclerosis (MS) diagnosis.
Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included.

Exclusion criteria

Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration.
Any active infection (e.g., active Hepatitis B virus \[HBV\])
Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.

Where it is running

60 locations listed across 35 US states.

TG Therapeutics Investigational Trial Site - Birmingham, Alabama, United States
TG Therapeutics Investigational Trial Site - Cullman, Alabama, United States
TG Therapeutics Investigational Trial Site - Huntsville, Alabama, United States
TG Therapeutics Investigational Trial Site - Mobile, Alabama, United States
TG Therapeutics Investigational Trial Site - Gilbert, Arizona, United States
TG Therapeutics Investigational Trial Site - Phoenix, Arizona, United States
TG Therapeutics Investigational Trial Site - Scottsdale, Arizona, United States
TG Therapeutics Investigational Trial Site - Fresno, California, United States
TG Therapeutics Investigational Trial Site - Newport Beach, California, United States
TG Therapeutics Investigational Trial Site - Orange, California, United States
TG Therapeutics Investigational Trial Site - West Hollywood, California, United States
TG Therapeutics Investigational Trial Site - Aurora, Colorado, United States
TG Therapeutics Investigational Trial Site - Basalt, Colorado, United States
TG Therapeutics Investigational Trial Site - Colorado Springs, Colorado, United States
TG Therapeutics Investigational Trial Site - Colorado Springs, Colorado, United States
TG Therapeutics Investigational Trial Site - Denver, Colorado, United States
TG Therapeutics Investigational Trial Site - Fort Collins, Colorado, United States
TG Therapeutics Investigational Trial Site - Grand Junction, Colorado, United States
TG Therapeutics Investigational Trial Site - Farmington, Connecticut, United States
TG Therapeutics Investigational Trial Site - Hartford, Connecticut, United States
TG Therapeutics Investigational Trial Site - Washington D.C., District of Columbia, United States
TG Therapeutics Investigational Trial Site - Altamonte Springs, Florida, United States
TG Therapeutics Investigational Trial Site - Boca Raton, Florida, United States
TG Therapeutics Investigational Trial Site - Clearwater, Florida, United States
TG Therapeutics Investigational Trial Site - Gainesville, Florida, United States
TG Therapeutics Investigational Trial Site - Maitland, Florida, United States
TG Therapeutics Investigational Trial Site - Miami, Florida, United States
TG Therapeutics Investigational Trial Site - Naples, Florida, United States
TG Therapeutics Investigational Trial Site - Orlando, Florida, United States
TG Therapeutics Investigational Trial Site - Pensacola, Florida, United States
TG Therapeutics Investigational Trial Site - Weston, Florida, United States
TG Therapeutics Investigational Trial Site - Atlanta, Georgia, United States
TG Therapeutics Investigational Trial Site - Atlanta, Georgia, United States
TG Therapeutics Investigational Trial Site - Savannah, Georgia, United States
TG Therapeutics Investigational Trial Site - Smyrna, Georgia, United States
TG Therapeutics Investigational Trial Site - Honolulu, Hawaii, United States
TG Therapeutics Investigational Trial Site - Coeur d'Alene, Idaho, United States
TG Therapeutics Investigational Trial Site - Chicago, Illinois, United States
TG Therapeutics Investigational Trial Site - Chicago, Illinois, United States
TG Therapeutics Investigational Trial Site - Evanston, Illinois, United States
TG Therapeutics Investigational Trial Site - Urbana, Illinois, United States
TG Therapeutics Investigational Trial Site - Avon, Indiana, United States
TG Therapeutics Investigational Trial Site - Roeland Park, Kansas, United States
TG Therapeutics Investigational Trial Site - Lexington, Kentucky, United States
TG Therapeutics Investigational Trial Site - Louisville, Kentucky, United States
TG Therapeutics Investigational Trial Site - Baltimore, Maryland, United States
TG Therapeutics Investigational Trial Site - Glen Burnie, Maryland, United States
TG Therapeutics Investigational Trial Site - Boston, Massachusetts, United States
TG Therapeutics Investigational Trial Site - Burlington, Massachusetts, United States
TG Therapeutics Investigational Trial Site - Norfolk, Massachusetts, United States
TG Therapeutics Investigational Trial Site - Ann Arbor, Michigan, United States
TG Therapeutics Investigational Trial Site - Detroit, Michigan, United States
TG Therapeutics Investigational Trial Site - Farmington, Michigan, United States
TG Therapeutics Investigational Trial Site - Owosso, Michigan, United States
TG Therapeutics Investigational Trial Site - Rochester Hills, Michigan, United States
TG Therapeutics Investigational Trial Site - Golden Valley, Minnesota, United States
TG Therapeutics Investigational Trial Site - Plymouth, Minnesota, United States
TG Therapeutics Investigational Trial Site - Billings, Montana, United States
TG Therapeutics Investigational Trial Site - Omaha, Nebraska, United States
TG Therapeutics Investigational Trial Site - Las Vegas, Nevada, United States

Showing 60 of 109 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →